Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Diseases, Interstitial | 6 | 2022 | 175 | 2.190 |
Why?
|
| Lung Diseases | 6 | 2025 | 408 | 1.700 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 3 | 2022 | 23 | 1.560 |
Why?
|
| Granulomatosis with Polyangiitis | 4 | 2022 | 34 | 1.240 |
Why?
|
| Churg-Strauss Syndrome | 3 | 2022 | 20 | 1.080 |
Why?
|
| Lung | 6 | 2024 | 1556 | 0.980 |
Why?
|
| STAT3 Transcription Factor | 3 | 2022 | 232 | 0.890 |
Why?
|
| Cough | 2 | 2023 | 96 | 0.860 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2020 | 559 | 0.800 |
Why?
|
| Immune System Diseases | 1 | 2022 | 52 | 0.750 |
Why?
|
| Hemoptysis | 1 | 2021 | 22 | 0.710 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2021 | 22 | 0.700 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 2022 | 216 | 0.660 |
Why?
|
| Janus Kinase Inhibitors | 1 | 2020 | 27 | 0.660 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 149 | 0.650 |
Why?
|
| Connective Tissue Diseases | 1 | 2019 | 32 | 0.630 |
Why?
|
| Pulmonary Medicine | 1 | 2019 | 29 | 0.620 |
Why?
|
| Pneumonia | 1 | 2022 | 334 | 0.580 |
Why?
|
| Hemorrhage | 2 | 2023 | 518 | 0.580 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2021 | 211 | 0.560 |
Why?
|
| Rheumatology | 1 | 2019 | 129 | 0.550 |
Why?
|
| Pyrazoles | 1 | 2020 | 330 | 0.550 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 463 | 0.490 |
Why?
|
| Escherichia coli O157 | 1 | 2014 | 6 | 0.440 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2014 | 36 | 0.430 |
Why?
|
| Gain of Function Mutation | 3 | 2022 | 111 | 0.380 |
Why?
|
| Status Epilepticus | 1 | 2014 | 157 | 0.380 |
Why?
|
| Escherichia coli Infections | 1 | 2014 | 192 | 0.370 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 3 | 2025 | 1192 | 0.350 |
Why?
|
| Mutation | 3 | 2024 | 6250 | 0.350 |
Why?
|
| Microscopic Polyangiitis | 2 | 2021 | 14 | 0.350 |
Why?
|
| Child | 12 | 2025 | 25784 | 0.330 |
Why?
|
| Kidney Diseases | 2 | 2023 | 490 | 0.280 |
Why?
|
| Cohort Studies | 3 | 2022 | 5176 | 0.280 |
Why?
|
| Child, Preschool | 8 | 2025 | 14736 | 0.270 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2022 | 659 | 0.230 |
Why?
|
| Coatomer Protein | 2 | 2023 | 30 | 0.230 |
Why?
|
| Infant | 6 | 2025 | 13049 | 0.230 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2023 | 2166 | 0.230 |
Why?
|
| Humans | 20 | 2025 | 132257 | 0.220 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 2 | 2022 | 30 | 0.220 |
Why?
|
| Dyspnea | 2 | 2023 | 160 | 0.220 |
Why?
|
| Lymphadenopathy | 1 | 2023 | 31 | 0.200 |
Why?
|
| Pleural Effusion | 1 | 2023 | 110 | 0.190 |
Why?
|
| Glomerulonephritis | 1 | 2023 | 74 | 0.190 |
Why?
|
| Arthritis | 1 | 2023 | 86 | 0.190 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 55 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2024 | 579 | 0.180 |
Why?
|
| Myeloblastin | 1 | 2021 | 12 | 0.180 |
Why?
|
| Hematuria | 1 | 2022 | 56 | 0.180 |
Why?
|
| Autoimmunity | 1 | 2022 | 181 | 0.180 |
Why?
|
| Myositis | 1 | 2022 | 105 | 0.180 |
Why?
|
| Glycogen Storage Disease | 1 | 2021 | 9 | 0.180 |
Why?
|
| Peroxidase | 1 | 2021 | 64 | 0.180 |
Why?
|
| Filamins | 1 | 2021 | 27 | 0.170 |
Why?
|
| Male | 10 | 2025 | 65019 | 0.170 |
Why?
|
| Lymphocytes | 1 | 2022 | 364 | 0.170 |
Why?
|
| Biopsy | 2 | 2024 | 1288 | 0.170 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 199 | 0.170 |
Why?
|
| Respiratory System Abnormalities | 1 | 2021 | 44 | 0.170 |
Why?
|
| France | 1 | 2020 | 88 | 0.170 |
Why?
|
| Pulmonary Alveoli | 1 | 2021 | 141 | 0.160 |
Why?
|
| Female | 11 | 2025 | 70792 | 0.160 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 273 | 0.140 |
Why?
|
| Autoantibodies | 1 | 2021 | 458 | 0.140 |
Why?
|
| Retrospective Studies | 5 | 2024 | 17396 | 0.140 |
Why?
|
| Recurrence | 1 | 2021 | 1453 | 0.130 |
Why?
|
| Hodgkin Disease | 1 | 2020 | 304 | 0.130 |
Why?
|
| Adolescent | 6 | 2025 | 20561 | 0.120 |
Why?
|
| Cell Proliferation | 1 | 2022 | 2511 | 0.110 |
Why?
|
| Disease Progression | 1 | 2021 | 2233 | 0.110 |
Why?
|
| Fatal Outcome | 1 | 2014 | 376 | 0.100 |
Why?
|
| Texas | 1 | 2020 | 3632 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2021 | 8548 | 0.090 |
Why?
|
| Syndrome | 2 | 2023 | 1175 | 0.080 |
Why?
|
| Survivors | 2 | 2022 | 358 | 0.070 |
Why?
|
| Treatment Outcome | 3 | 2024 | 13031 | 0.070 |
Why?
|
| Adult | 3 | 2025 | 31620 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2961 | 0.070 |
Why?
|
| Registries | 2 | 2022 | 1591 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2025 | 212 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2024 | 169 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 5412 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 196 | 0.050 |
Why?
|
| Fibrosis | 1 | 2023 | 421 | 0.040 |
Why?
|
| Young Adult | 2 | 2025 | 9970 | 0.040 |
Why?
|
| Middle Aged | 1 | 2020 | 29027 | 0.040 |
Why?
|
| Survival Rate | 1 | 2025 | 2196 | 0.040 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 313 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 622 | 0.040 |
Why?
|
| Prevalence | 1 | 2025 | 2664 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1966 | 0.030 |
Why?
|
| Prognosis | 1 | 2025 | 5016 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2025 | 6569 | 0.030 |
Why?
|
| Incidence | 1 | 2020 | 3377 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 10946 | 0.010 |
Why?
|